Uniklinik Köln

Running trials

• Not yet recruiting

  Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial

  NCT07840456· Phase 2· Source

• Recruiting

  PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Intervention - Study

  NCT07621003· Source

• Recruiting

  Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps

  NCT06765226· Source

• Recruiting

  FMRI-neurofeedback in Parkinson's Disease

  NCT06582355· Source

• Active, not recruiting

  A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

  NCT06559163· Phase 2· Source

• Recruiting

  Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

  NCT06553625· Source

• Enrolling by invitation

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· Phase 3· Source

• Active, not recruiting

  Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer

  NCT04246203· Source

• Active, not recruiting

  Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease

  NCT05043103· Source

• Active, not recruiting

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Source

• Active, not recruiting

  MINIject Global Long-Term Follow-up Study

  NCT04524416· Source

• Recruiting

  Deep Brain Stimulation (DBS) Retrospective Outcomes Study

  NCT03664609· Source

• Enrolling by invitation

  Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

  NCT03391778· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Parkinson disease3 recruiting
• Amyloidosis1 recruiting
• Atrial fibrillation1 recruiting
• Childhood cancers1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Recruiting

  A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

  NCT05091424· Phase 1· Source

• Completed

  A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

  NCT04968912· Phase 2· Source

• Completed

  Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer

  NCT04257448· Phase 1/2· Source

• Completed

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· Phase 3· Source

• Completed

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· Phase 3· Source

• Recruiting

  Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

  NCT02071134· Source

• Completed

  A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma

  NCT01650701· Phase 3· Source